176 related articles for article (PubMed ID: 17855570)
21. [Susceptibility testing of Mycobacterium tuberculosis isolates to primary antituberculous drugs on chocolate agar: a preliminary study].
Coban AY; Bilgin K; Akgüneş A; Durupinar B
Mikrobiyol Bul; 2008 Jul; 42(3):477-81. PubMed ID: 18822892
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
[TBL] [Abstract][Full Text] [Related]
23. Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.
Johansen IS; Larsen AR; Sandven P; Petrini B; Soini H; Levina K; Sosnovskaja A; Skenders G; Hoffner S
Int J Tuberc Lung Dis; 2003 Sep; 7(9):899-902. PubMed ID: 12971676
[TBL] [Abstract][Full Text] [Related]
24. [External control of drug sensitivity determination in mycobacteriologic laboratories in the Czech Republic].
Havelková M; Slosárek M; Janota J
Epidemiol Mikrobiol Imunol; 1994 Dec; 43(4):162-5. PubMed ID: 7850216
[TBL] [Abstract][Full Text] [Related]
25. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs].
Delás MA; Martínez C; Yagüe C; Rodríguez T; Rodríguez T; Segovia M
Rev Esp Quimioter; 2001 Mar; 14(1):40-6. PubMed ID: 11376348
[TBL] [Abstract][Full Text] [Related]
27. First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China.
Jiang GL; Chen X; Song Y; Zhao Y; Huang H; Kam KM
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1491-4. PubMed ID: 24125456
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil.
Shikama Mde L; Silva RR; Martins MC; Giampaglia CM; Oliveira RS; Silva RF; Silva PF; Telles MA; Martin A; Palomino JC
J Antimicrob Chemother; 2009 Oct; 64(4):794-6. PubMed ID: 19671589
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
[TBL] [Abstract][Full Text] [Related]
30. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan, 2007-2011.
Wu MH; Chiang CY; Deng YM; Wang TF; Jou R
Int J Tuberc Lung Dis; 2013 Jan; 17(1):113-9. PubMed ID: 23232011
[TBL] [Abstract][Full Text] [Related]
31. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
32. Has the time come to discontinue proficiency testing?
Salfinger M; Ahmedov S
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1193. PubMed ID: 19793421
[No Abstract] [Full Text] [Related]
33. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
34. [Resistance rates to antituberculous drugs in Sivas province].
Gönlügür U; Bakici MZ; Gönlügür TE; Hasbek M
Mikrobiyol Bul; 2007 Jul; 41(3):459-63. PubMed ID: 17933259
[TBL] [Abstract][Full Text] [Related]
35. External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
Shu W; Du J; Liu Y; Wang Y; Huo F; Jiang G; Li L; Pang Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):871-875. PubMed ID: 31898799
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
Bernardelli A; Morcillo N; Loureiro J; Quse V; Davenport S
Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
[TBL] [Abstract][Full Text] [Related]
37. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
38. [Drug susceptibility testing for M. tuberculosis with proportion method].
Liu Y; Wang S; Na X
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):89-92. PubMed ID: 11778497
[TBL] [Abstract][Full Text] [Related]
39. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of susceptibility testing results of M. tuberculosis by different methods].
Ding B; Zhao T; Gai Y
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):423-5. PubMed ID: 11778510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
